260 related articles for article (PubMed ID: 26775556)
41. Activated YAP causes renal damage of type 2 diabetic nephropathy.
Ma R; Ren JM; Li P; Zhou YJ; Zhou MK; Hu Z; Xiao XY
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):755-763. PubMed ID: 30720184
[TBL] [Abstract][Full Text] [Related]
42. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors.
Kato M; Zhang J; Wang M; Lanting L; Yuan H; Rossi JJ; Natarajan R
Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3432-7. PubMed ID: 17360662
[TBL] [Abstract][Full Text] [Related]
43. MALAT1-miR-30c-5p-CTGF/ATG5 axis regulates silica-induced experimental silicosis by mediating EMT in alveolar epithelial cells.
Xia J; Tian Y; Shao Z; Li C; Ding M; Qi Y; Xu X; Dai K; Wu C; Yao W; Hao C
Ecotoxicol Environ Saf; 2023 Jan; 249():114392. PubMed ID: 36508811
[TBL] [Abstract][Full Text] [Related]
44. Circular RNA HIPK3 exacerbates diabetic nephropathy and promotes proliferation by sponging miR-185.
Liu R; Zhang M; Ge Y
Gene; 2021 Jan; 765():145065. PubMed ID: 32889056
[TBL] [Abstract][Full Text] [Related]
45. Regulation of TIMP3 in diabetic nephropathy: a role for microRNAs.
Fiorentino L; Cavalera M; Mavilio M; Conserva F; Menghini R; Gesualdo L; Federici M
Acta Diabetol; 2013 Dec; 50(6):965-9. PubMed ID: 23797704
[TBL] [Abstract][Full Text] [Related]
46. ATP synthase subunit-β down-regulation aggravates diabetic nephropathy.
Guan SS; Sheu ML; Wu CT; Chiang CK; Liu SH
Sci Rep; 2015 Oct; 5():14561. PubMed ID: 26449648
[TBL] [Abstract][Full Text] [Related]
47. Effect of loganin on experimental diabetic nephropathy.
Jiang WL; Zhang SP; Hou J; Zhu HB
Phytomedicine; 2012 Feb; 19(3-4):217-22. PubMed ID: 21978885
[TBL] [Abstract][Full Text] [Related]
48. Epigenetic activation of CTGF transcription by high glucose in renal tubular epithelial cells is mediated by myocardin-related transcription factor A.
Shao J; Xu H; Wu X; Xu Y
Cell Tissue Res; 2020 Mar; 379(3):549-559. PubMed ID: 31773302
[TBL] [Abstract][Full Text] [Related]
49. Renal Tissue-Derived Exosomal miRNA-34a in Diabetic Nephropathy Induces Renal Tubular Cell Fibrosis by Promoting the Polarization of M1 Macrophages.
Zheng S; Zeng Y; Chu L; Gong T; Li S; Yang M
IET Nanobiotechnol; 2024; 2024():5702517. PubMed ID: 38863972
[TBL] [Abstract][Full Text] [Related]
50. Long noncoding RNA TUG1 alleviates extracellular matrix accumulation via mediating microRNA-377 targeting of PPARγ in diabetic nephropathy.
Duan LJ; Ding M; Hou LJ; Cui YT; Li CJ; Yu DM
Biochem Biophys Res Commun; 2017 Mar; 484(3):598-604. PubMed ID: 28137588
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathy.
Zanchi C; Macconi D; Trionfini P; Tomasoni S; Rottoli D; Locatelli M; Rudnicki M; Vandesompele J; Mestdagh P; Remuzzi G; Benigni A; Zoja C
Diabetologia; 2017 Jun; 60(6):1114-1125. PubMed ID: 28364255
[TBL] [Abstract][Full Text] [Related]
52. Regulation of miR-29b and miR-30c by vitamin D receptor activators contributes to attenuate uraemia-induced cardiac fibrosis.
Panizo S; Carrillo-López N; Naves-Díaz M; Solache-Berrocal G; Martínez-Arias L; Rodrigues-Díez RR; Fernández-Vázquez A; Martínez-Salgado C; Ruiz-Ortega M; Dusso A; Cannata-Andía JB; Rodríguez I
Nephrol Dial Transplant; 2017 Nov; 32(11):1831-1840. PubMed ID: 28460073
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA‑379‑5p suppresses renal fibrosis by regulating the LIN28/let‑7 axis in diabetic nephropathy.
Li N; Wang LJ; Xu WL; Liu S; Yu JY
Int J Mol Med; 2019 Nov; 44(5):1619-1628. PubMed ID: 31485601
[TBL] [Abstract][Full Text] [Related]
54. miR-451 suppresses the NF-kappaB-mediated proinflammatory molecules expression through inhibiting LMP7 in diabetic nephropathy.
Sun Y; Peng R; Peng H; Liu H; Wen L; Wu T; Yi H; Li A; Zhang Z
Mol Cell Endocrinol; 2016 Sep; 433():75-86. PubMed ID: 27264074
[TBL] [Abstract][Full Text] [Related]
55. circ_000166/miR-296 Aggravates the Process of Diabetic Renal Fibrosis by Regulating the SGLT2 Signaling Pathway in Renal Tubular Epithelial Cells.
Chen S
Dis Markers; 2022; 2022():6103086. PubMed ID: 35615399
[TBL] [Abstract][Full Text] [Related]
56. Long Noncoding RNA H19 Acts as a Competing Endogenous RNA to Mediate CTGF Expression by Sponging miR-455 in Cardiac Fibrosis.
Huang ZW; Tian LH; Yang B; Guo RM
DNA Cell Biol; 2017 Sep; 36(9):759-766. PubMed ID: 28753062
[TBL] [Abstract][Full Text] [Related]
57. CCN2/CTGF increases expression of miR-302 microRNAs, which target the TGFβ type II receptor with implications for nephropathic cell phenotypes.
Faherty N; Curran SP; O'Donovan H; Martin F; Godson C; Brazil DP; Crean JK
J Cell Sci; 2012 Dec; 125(Pt 23):5621-9. PubMed ID: 22976296
[TBL] [Abstract][Full Text] [Related]
58. Aldose reductase regulates miR-200a-3p/141-3p to coordinate Keap1-Nrf2, Tgfβ1/2, and Zeb1/2 signaling in renal mesangial cells and the renal cortex of diabetic mice.
Wei J; Zhang Y; Luo Y; Wang Z; Bi S; Song D; Dai Y; Wang T; Qiu L; Wen L; Yuan L; Yang JY
Free Radic Biol Med; 2014 Feb; 67():91-102. PubMed ID: 24161443
[TBL] [Abstract][Full Text] [Related]
59. miR‑132 in atrial fibrillation directly targets connective tissue growth factor.
Qiao G; Xia D; Cheng Z; Zhang G
Mol Med Rep; 2017 Oct; 16(4):4143-4150. PubMed ID: 28731126
[TBL] [Abstract][Full Text] [Related]
60. miR-543 regulates high glucose-induced fibrosis and autophagy in diabetic nephropathy by targeting TSPAN8.
Zhuang L; Ge X; Hu X; Yang Q; Pei X; Jin G
BMC Nephrol; 2022 Mar; 23(1):89. PubMed ID: 35246069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
